AORT earnings date and last-quarter result: next report 2026-08-06, last quarter miss, P/E 100.28. Updated 2026-07-23.
Artivion (AORT) Research Hub
Artivion (AORT) trades on NYSE, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 22.98 USD (-1.37%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 100.28, market cap 1.22B. This hub links to the full technical, earnings and options research available for AORT.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NYSE, US |
| Last close | 22.98 USD (-1.37%) |
| 52-week range | 19.88 USD – 30.14 USD |
| Trend regime | Range |
| 14-day RSI | 59.8 (Bullish) |
| Trailing P/E | 100.28 |
| Market cap | 1.22B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-06 |
Available research for AORT
Covered Call on AORT: how it works, illustrative setup around the real 22.98 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on AORT: how it works, illustrative setup around the real 22.98 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on AORT: how it works, illustrative setup around the real 22.98 USD price, max profit/loss, breakeven and when to use it. Educational.
AORT technical analysis: range, last 22.98 USD, RSI 59.8, 52w range 19.88 USD–30.14 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is AORT in?
Artivion (AORT) is classified under Healthcare (Medical - Devices), listed on NYSE, US.
Is AORT in an uptrend or downtrend?
As of 2026-10-26, AORT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is AORT's trailing P/E ratio?
AORT's trailing P/E is 100.28, with a market cap of 1.22B. See the earnings research page for full valuation detail.
When does AORT next report earnings?
AORT is next scheduled to report earnings on 2026-08-06.